JP2024513644A5 - - Google Patents
Info
- Publication number
- JP2024513644A5 JP2024513644A5 JP2023550275A JP2023550275A JP2024513644A5 JP 2024513644 A5 JP2024513644 A5 JP 2024513644A5 JP 2023550275 A JP2023550275 A JP 2023550275A JP 2023550275 A JP2023550275 A JP 2023550275A JP 2024513644 A5 JP2024513644 A5 JP 2024513644A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antigen
- binding molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10202101681W | 2021-02-19 | ||
| SG10202101681W | 2021-02-19 | ||
| PCT/EP2022/054137 WO2022175481A1 (en) | 2021-02-19 | 2022-02-18 | Vegfa-binding molecules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024513644A JP2024513644A (ja) | 2024-03-27 |
| JP2024513644A5 true JP2024513644A5 (enExample) | 2025-02-26 |
Family
ID=80685523
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023550552A Active JP7827737B2 (ja) | 2021-02-19 | 2022-02-18 | Ｖｅｇｆａ結合分子 |
| JP2023550275A Pending JP2024513644A (ja) | 2021-02-19 | 2022-02-18 | Ｖｅｇｆａ結合分子 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023550552A Active JP7827737B2 (ja) | 2021-02-19 | 2022-02-18 | Ｖｅｇｆａ結合分子 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20240228602A9 (enExample) |
| EP (2) | EP4294839A1 (enExample) |
| JP (2) | JP7827737B2 (enExample) |
| KR (2) | KR20230165902A (enExample) |
| CN (2) | CN117279941A (enExample) |
| AR (1) | AR124917A1 (enExample) |
| AU (2) | AU2022223337A1 (enExample) |
| CA (2) | CA3208389A1 (enExample) |
| WO (2) | WO2022175474A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024055995A1 (zh) * | 2022-09-14 | 2024-03-21 | 寻济生物科技（北京）有限公司 | 一种抗vegfa融合蛋白及其制备方法和应用 |
| JP2025534252A (ja) * | 2022-09-14 | 2025-10-15 | 尋済生物科技（北京）有限公司 | 抗ｖｅｇｆａ抗体またはその抗原結合フラグメント、およびその使用 |
| CN119039450A (zh) * | 2023-05-22 | 2024-11-29 | 上海君实生物医药科技股份有限公司 | 抗pd-1-抗vegf的双特异性抗体、其药物组合物及其用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ580530A (en) * | 2007-06-06 | 2012-04-27 | Domantis Ltd | Anti vegf polypeptides, antibody variable domains and antagonists |
| KR100883430B1 (ko) * | 2007-06-13 | 2009-02-12 | 한국생명공학연구원 | 혈관내피성장인자 수용체를 중화하는 인간 단클론항체 및그 용도 |
| US20120225081A1 (en) * | 2010-09-03 | 2012-09-06 | Boehringer Ingelheim International Gmbh | Vegf-binding molecules |
| US9527925B2 (en) * | 2011-04-01 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Bispecific binding molecules binding to VEGF and ANG2 |
| JP5987057B2 (ja) * | 2011-07-27 | 2016-09-06 | グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ | Ｆｃドメインと融合した抗ｖｅｇｆ単一可変ドメイン |
| JP6921743B2 (ja) * | 2014-11-05 | 2021-08-18 | ナンヤン テクノロジカル ユニヴァーシティー | 安定化かつ自律性抗体ｖｈドメイン |
| AU2015376558B9 (en) * | 2015-01-06 | 2021-07-01 | Zhuhai Essex Bio-Pharmaceutical Co., Ltd. | Anti-VEGF antibody |
| EP3565898A4 (en) * | 2017-01-05 | 2021-05-26 | Helix Biopharma Corp. | VEGFR-2-CAR IMMUNE CELLS FOR TREATMENT OF CANCER |
| CN110452297B (zh) * | 2019-09-03 | 2020-04-14 | 上海洛启生物医药技术有限公司 | 抗vegf单域抗体及其应用 |
-
2022
- 2022-02-18 CA CA3208389A patent/CA3208389A1/en active Pending
- 2022-02-18 KR KR1020237031776A patent/KR20230165902A/ko active Pending
- 2022-02-18 CN CN202280029374.9A patent/CN117279941A/zh active Pending
- 2022-02-18 EP EP22709293.9A patent/EP4294839A1/en active Pending
- 2022-02-18 JP JP2023550552A patent/JP7827737B2/ja active Active
- 2022-02-18 KR KR1020237031774A patent/KR20230165901A/ko active Pending
- 2022-02-18 CN CN202280015698.7A patent/CN117242092A/zh active Pending
- 2022-02-18 AR ARP220100348A patent/AR124917A1/es unknown
- 2022-02-18 AU AU2022223337A patent/AU2022223337A1/en active Pending
- 2022-02-18 WO PCT/EP2022/054123 patent/WO2022175474A1/en not_active Ceased
- 2022-02-18 WO PCT/EP2022/054137 patent/WO2022175481A1/en not_active Ceased
- 2022-02-18 EP EP22708095.9A patent/EP4294838A1/en active Pending
- 2022-02-18 US US18/277,749 patent/US20240228602A9/en active Pending
- 2022-02-18 AU AU2022222311A patent/AU2022222311A1/en active Pending
- 2022-02-18 CA CA3208368A patent/CA3208368A1/en active Pending
- 2022-02-18 US US18/277,738 patent/US20240228601A9/en active Pending
- 2022-02-18 JP JP2023550275A patent/JP2024513644A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021129572A (ja) | グリコシル化ｐｄ−ｌ１に特異的な抗体およびその使用方法 | |
| JP2022508747A (ja) | 新規抗－ｃ－ｋｉｔ抗体 | |
| JP6608698B2 (ja) | Ｐ２ｘ７受容体アンタゴニスト及びアゴニスト | |
| MX2010011955A (es) | Inmunoglobulinas de dominio variable doble y usos de las mismas. | |
| JP2024091842A (ja) | 抗ｃｄ３抗体及び該抗体を含む分子 | |
| WO2019042119A1 (zh) | 抗人cd47抗体及其用途 | |
| WO2019098763A9 (ko) | 알파-시누클레인에 대한 항체 및 그 용도 | |
| CA2947602A1 (en) | Methods for characterizing and treating acute myeloid leukemia | |
| CN111741975A (zh) | 抗血管生成素-2抗体及其用途 | |
| WO2022068809A1 (zh) | 抗cd3抗体以及其用途 | |
| JP2022516071A5 (enExample) | ||
| JP2021517807A (ja) | 抗ｐｄ−１抗体及びその用途 | |
| JP2024512260A5 (enExample) | ||
| JP7377185B2 (ja) | 抗ヒトｔｌｒ７抗体 | |
| CN116323664A (zh) | 抗β细胞素抗体、其片段和多特异性结合分子 | |
| JP2026031937A (ja) | 抗グリカン抗体及びそれらの使用 | |
| JP2024529119A5 (enExample) | ||
| CN117858721A (zh) | 用于治疗α-突触核蛋白病的抗体 | |
| CN111763258B (zh) | 抗ox40抗体及其用途 | |
| CN111479827B (zh) | 结合hERG1和hERG1/整联蛋白β1的单特异性和双特异性抗体 | |
| JP7808831B2 (ja) | 抗ｃｄ２６抗体とその応用 | |
| JP2022524175A (ja) | Ｅｌｔｄ１に対するモノクローナル抗体及びその使用 | |
| JP7561433B2 (ja) | 糖尿病網膜症の予防又は治療薬 | |
| CN116375874A (zh) | 一种cd33抗体及其应用 | |
| JP2025512137A (ja) | 抗ｍｉｃａ／ｂ抗体及びその使用 |